Last reviewed · How we verify

NCT05773534

Calf Muscle Perfusion in Patients With Intermittent Claudication by 3D-reconstruction of MSOT (MSOT_IC_3D)

Status unknown Last updated 17 March 2023
What this trial tests

trial testing MSOT in Diagnostic Imaging in 30 participants. Status unknown.

Timeline
27 February 2022
Primary endpoint
31 March 2023
31 May 2023

Quick facts

Lead sponsorUlrich Rother
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment30
Start date27 February 2022
Primary completion31 March 2023
Estimated completion31 May 2023
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Ulrich Rother

Who can join

18 and older, any sex, with Diagnostic Imaging or Peripheral Arterial Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the proposed study is to define independent parameters for the diagnostic assessment of the perfusion situation of the calf muscle based on 3D-reconstruction of multispectral optoacoustic tomography (MSOT) in a cross-sectional collective of patients with PAD in Fontaine stage II and a healthy control group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Shortcut learning leads to sex bias in deep learning models for photoacoustic tomography.
    Knopp M, Bender CJ, Holzwarth N, Li Y, et al · · 2025 · cited 1× · PMID 40343639 · DOI 10.1007/s11548-025-03370-9

Verify or expand the search:

Other trials of MSOT

Trials testing the same drug.

Other recruiting trials for Diagnostic Imaging

Currently open trials in the same condition.

Other Ulrich Rother trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05773534.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing